Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Obesity Drug Stocks Go Wild After Belviq Approval
Obesity Drug Stocks Go Wild After Belviq Approval
Obesity Drug Stocks Go Wild After Belviq Approval
Submitted by
admin
on June 28, 2012 - 6:14pm
Source:
Investors.com
News Tags:
obesity
lorcaserin
Belviq
Arena Pharmaceuticals
Orexigen
Vivus
Headline:
Obesity Drug Stocks Go Wild After Belviq Approval
Do Not Allow Advertisers to Use My Personal information
